Eisai Co Ltd
(FRA:EIIA)
€
10.1
0 (0%)
Market Cap: 11.39 Bil
Enterprise Value: 10.65 Bil
PE Ratio: 42.48
PB Ratio: 1.72
GF Score: 57/100 Eisai Co Ltd FDA Grants Accelerated Approval for ADUHELM Presentation Transcript
Jun 09, 2021 / 02:00AM GMT
Unidentified Company Representative
Presentation
Jun 09, 2021 / 02:00AM GMT
=====================
Corporate Participants
=====================
* Haruo Naito
Eisai Co., Ltd. - CEO, Representative Corporate Officer & Director
* Ivan Cheung
Eisai Co., Ltd. - Senior VP & President of Neurology Business Group
* Shuhei Shimizu
* Teiji Kimura
Eisai Co., Ltd. - VP & Chief Discovery Officer of Neurology Business Group
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division - Senior Analyst
=====================
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot